Recorded an extraordinary loss of 1,485 million yen for impairment on equity-method investments in the 2025 December non-consolidated financial results. No impact on consolidated financial results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4776","jir_company_name":"Cybozu, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-02-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4776-20260210-01.pdf","jir_short_summary":"Recorded an extraordinary loss of 1,485 million yen for impairment on equity-method investments in the 2025 December non-consolidated financial results. No impact on consolidated financial results.","jir_summary":"### Overview of the Extraordinary Loss\nCybozu, Inc. recorded an impairment loss of 1,485 million yen on the shares of Kintone Corporation, a consolidated subsidiary, as an extraordinary loss in its non-consolidated financial results for the fiscal year ending December 2025. Although losses temporarily accumulated due to the investment phase of the U.S. business, the company expects long-term growth potential and plans to continue investments.\n\n### Impact on Earnings and Consolidated Financial Results\nThis extraordinary loss is already reflected in the previously disclosed full-year non-consolidated earnings projection for the fiscal year ending December 2025 and is eliminated in consolidation, thus having no impact. Investors should note that there will be no changes to consolidated earnings.","jir_financial_highlights":"Impairment Loss on Equity-Method Investments (Extraordinary Loss): 1,485 million yen (Unknown)\nImpact on Consolidated Financial Results: None (Unknown)","jir_category":"","jir_hashtags":"#CybozuInc, #financial_summary, #JapaneseStocks","jir_key_figures":"Extraordinary Loss Amount: 1,485 million yen (Impairment loss on equity-method investments)\nTarget Company: Kintone Corporation (consolidated subsidiary)\nImpact on Consolidated Financial Results: None","jir_meta_title":"Cybozu, Inc. Records Extraordinary Loss of 1,485 Million Yen in 2025 December Non-Consolidated Financial Results","jir_meta_description":"Cybozu, Inc. posted an extraordinary loss of 1,485 million yen for impairment on equity-method investments in its non-consolidated financial results for the fiscal year ending December 2025. No impact on consolidated results, and investment in the U.S. business will continue.","jir_og_title":"Cybozu Records Extraordinary Loss in 2025 December Non-Consolidated Financial Results","jir_og_description":"Cybozu, Inc. recorded an extraordinary loss of 1,485 million yen in its non-consolidated financial results for the fiscal year ending December 2025. There is no impact on consolidated financial results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9194,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-27070","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n